Wang P-H, Ko J-L
Department of Obstetrics and Gynecology, Chung Shan Medical University Hospital, Taichung, Taiwan, ROC.
Int J Gynecol Cancer. 2006 Sep-Oct;16(5):1873-9. doi: 10.1111/j.1525-1438.2006.00659.x.
The objective of this study was to evaluate the implication of human telomerase reverse transcriptase (hTERT) in cervical carcinogenesis and cancer recurrence. One hundred three cases of uterine cervix, including 20 normal, 13 low-grade squamous intraepithelial lesion (LSIL), 30 high-grade squamous intraepithelial lesion (HSIL), and 40 squamous cell carcinoma (SCC) tissues, were evaluated for hTERT immunoreactivity. The expressions of hTERT in normal, LSIL, HSIL, and SCC tissues were compared by Fisher exact or Chi-square test. The relationships between hTERT and clinicopathologic variables of SCC were also assessed. Furthermore, SCC patients were subdivided into negative and positive hTERT expression subgroups, and Kaplan-Meier curves were used to plot the cumulative recurrence hazard for 5 years. There was a significant difference for hTERT expression between LSIL and HSIL subgroups (P < 0.001) but no significant difference between normal and LSIL as well as HSIL and SCC subgroups. For SCC patients, hTERT expression was positive in lymph nodes, vagina, and parametrium metastastic cases. However, it did not reach a significant difference. The cumulative recurrence hazard for 5 years was about 29% in positive hTERT expression subgroup compared to 0% in negative hTERT subgroup (P = 0.2866). In conclusion, a point stage of HSIL exists in the progression of cervical carcinogenesis when the hTERT expression increases significantly. Moreover, SCC patients with positive hTERT expression may have higher cumulative recurrence hazard.
本研究的目的是评估人类端粒酶逆转录酶(hTERT)在子宫颈癌发生和癌症复发中的作用。对103例子宫颈组织进行评估,包括20例正常组织、13例低级别鳞状上皮内病变(LSIL)、30例高级别鳞状上皮内病变(HSIL)和40例鳞状细胞癌(SCC)组织,检测hTERT免疫反应性。采用Fisher精确检验或卡方检验比较hTERT在正常、LSIL、HSIL和SCC组织中的表达。还评估了hTERT与SCC临床病理变量之间的关系。此外,将SCC患者分为hTERT表达阴性和阳性亚组,采用Kaplan-Meier曲线绘制5年累积复发风险。LSIL和HSIL亚组之间hTERT表达存在显著差异(P < 0.001),但正常与LSIL以及HSIL与SCC亚组之间无显著差异。对于SCC患者,hTERT表达在淋巴结、阴道和宫旁转移病例中呈阳性。然而,差异无统计学意义。hTERT表达阳性亚组5年累积复发风险约为29%,而hTERT表达阴性亚组为0%(P = 0.2866)。总之,在子宫颈癌发生进展过程中,当hTERT表达显著增加时存在HSIL这一阶段。此外,hTERT表达阳性的SCC患者可能具有更高的累积复发风险。